3don MSN
A scalpel that can diagnose? Scientists unveil a 'Lab-on-a-Scalpel' for real-time surgical insights
Imagine a surgeon in the middle of a complex operation, able to get instant biochemical feedback not from a lab down the hall ...
LeBron James remains sidelined for the Lakers' November 4th clash against the Trail Blazers due to a persistent sciatica ...
New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, ...
NRG Therapeutics made three senior appointments in newly created roles: Sarah Almond as VP of translational biology; David Brocklebank as director of clinical operations and Kathryn Oliver as director ...
The authorities have decided to reduce the minimum requirement score by 0.5 percent for the MBBS and dental admission test ...
Tina Ambani, wife of Anil Ambani is a dedicated philanthropist, known for her contributions to various social causes and ...
15hon MSN
Venomous or poisonous? Know how snakes, frogs, and plants use toxins in strikingly different ways
Nature's deadliest creatures employ distinct defense mechanisms. Venomous animals inject toxins through bites or stings, like cobras and jellyfish. Po ...
News-Medical.Net on MSN
Experimental compound reduces cell death, inflammation, and organ damage in diabetes
An experimental compound reduced the cell death, inflammation, and organ damage seen with diabetes.
Healing hydrogels—cross-linked polymer chains that hold a lot of water—can promote tissue healing and prevent postsurgical complications. But the current method of delivery, using a needle from the ...
News-Medical.Net on MSN
Breakthrough could offer a new therapeutic option for stopping diabetes-induced complications
Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...
Panelists discuss how prescription digital therapeutics differ from traditional pharmaceuticals by following FDA medical ...
M is positioned as the first oral antiviral sugar chemistry drug BOSTON, MASSACHUSETTS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the 'Company”), a clinical stage biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results